Cirrhosis of the Liver, Re-stenosis
Conditions
Keywords
LTX Study
Brief summary
The aim of the study is to choose an optimal stent and to get further knowledge about the mechanisms of the engraftment of a stent. The occurrence of a hyperplasia of neointima can be minimized by application of a coated stent and a concurrent safety four weekly dual thrombocytes therapy
Interventions
DEVICEZES
stent implantation (zotarolimus eluting stent)
DEVICEBMS
stent implantation (bare metal stent)
Sponsors
RWTH Aachen University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* male and female patients with a severe dysfunction of liver * patient is planned a coronary stent implantation * adults who are contractually capable and mentally able to understand and follow the instructions of the study personnel * written informed consent prior to study participation
Exclusion criteria
* younger than 18 years * pregnancy and breast-feeding * acute cardiac syndrome * contraindication against an intracardiac catheter * persons in dependence from the sponsor or working with the sponsor * participation in a parallel interventional clinical trial * patient has been committed to an institution by legal or regulatory order
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the ideal stent (coated stent or uncoated stent) | 5 weeks |
Outcome results
None listed